Article info
Extended report
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study
- Correspondence to:
Professor J-Y Reginster
Unité d’Exploration du Metabolisme de l’Os et du Cartilage, CHU Centre Ville, Liège, Belgium; jyreginster{at}ulg.ac.be
Citation
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study
Publication history
- Accepted November 27, 2005
- First published December 8, 2005.
Online issue publication
December 29, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Annals of the Rheumatic Diseases